444

NOILE-IMMUNE BIOTECH INC

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪7.49 B‬JPY
‪−1.13 B‬JPY
‪316.82 M‬JPY
‪7.98 M‬
Beta (1Y)
0.73

About NOILE-IMMUNE BIOTECH INC

Headquarters
Tokyo
Employees (FY)
28
Founded
2015
ISIN
JP3759560000
FIGI
BBG01FKBX2N2
Noile-Immune Biotech, Inc. engages in the development of CAR-T cell therapy, a cancer immunotherapy for solid tumors using proprietary technology. The company was founded on April 16, 2015 and is headquartered in Tokyo, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 4893 is 158 JPY — it has decreased by 2.47% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange NOILE-IMMUNE BIOTECH INC stocks are traded under the ticker 4893.
NOILE-IMMUNE BIOTECH INC is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
4893 stock is 3.82% volatile and has beta coefficient of 0.73. Check out the list of the most volatile stocks — is NOILE-IMMUNE BIOTECH INC there?
Yes, you can track NOILE-IMMUNE BIOTECH INC financials in yearly and quarterly reports right on TradingView.
4893 stock has risen by 3.27% compared to the previous week, the month change is a 16.84% fall, over the last year NOILE-IMMUNE BIOTECH INC has showed a 77.27% decrease.
4893 net income for the last quarter is ‪−279.58 M‬ JPY, while the quarter before that showed ‪−16.88 M‬ JPY of net income which accounts for ‪−1.56 K‬% change. Track more NOILE-IMMUNE BIOTECH INC financial stats to get the full picture.
Today NOILE-IMMUNE BIOTECH INC has the market capitalization of ‪7.01 B‬, it has decreased by 11.86% over the last week.
No, 4893 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4893 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOILE-IMMUNE BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
4893 reached its all-time high on Jun 28, 2023 with the price of 775 JPY, and its all-time low was 150 JPY and was reached on Apr 19, 2024.
See other stocks reaching their highest and lowest prices.
As of May 1, 2024, the company has 28.00 employees. See our rating of the largest employees — is NOILE-IMMUNE BIOTECH INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOILE-IMMUNE BIOTECH INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOILE-IMMUNE BIOTECH INC stock shows the buy signal. See more of NOILE-IMMUNE BIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOILE-IMMUNE BIOTECH INC EBITDA is ‪−775.39 M‬ JPY, and current EBITDA margin is −244.74%. See more stats in NOILE-IMMUNE BIOTECH INC financial statements.